Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China flag China · Delayed Price · Currency is CNY
14.78
-0.25 (-1.66%)
May 12, 2026, 3:00 PM CST

SHA:688526 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
198.57176.8543.48581.74456.07555.36
Short-Term Investments
-664.39669.19451.14810547.35
Trading Asset Securities
1,6811,542719.51745.04674.83212.95
Cash & Short-Term Investments
1,8802,3831,9321,7781,9411,316
Cash Growth
40.39%23.36%8.68%-8.40%47.52%-39.76%
Accounts Receivable
332.44302.6354.81343.15406.52294.4
Other Receivables
3.934.324.8737.4734.9632.02
Receivables
336.37366.92359.69635.68441.48326.42
Inventory
136.3144.27125.6144.8169.4108.82
Other Current Assets
757.6232.4155.627.699.1210.42
Total Current Assets
3,1102,9272,4732,5662,5611,761
Property, Plant & Equipment
849.46877.95887.05858.9905.38904.15
Long-Term Investments
56.68907.161,0571,136799.2940.15
Goodwill
---3.313.31-
Other Intangible Assets
64.6565.7165.160.0359.9157.24
Long-Term Deferred Tax Assets
0.490.50.960.326.816.28
Long-Term Deferred Charges
0.991.121.61.18--
Other Long-Term Assets
742.299.710.9845.8835.1346.2
Total Assets
4,8254,7894,4964,6714,3913,725
Accounts Payable
110.87111.32178.26165.03244.27215.74
Accrued Expenses
20.8279.9287.6488.3692.7976.04
Short-Term Debt
---206.65131.618.03
Current Portion of Long-Term Debt
0.97--80.05-60.06
Current Portion of Leases
-1.611.351.060.65-
Current Income Taxes Payable
33.7546.6930.7753.9831.0946.83
Current Unearned Revenue
191.75182.37148.6157.61101.763.18
Other Current Liabilities
61.0135.5816.875.5121.7412.35
Total Current Liabilities
419.17457.5463.5758.25623.84492.24
Long-Term Debt
----140.11-
Long-Term Leases
5.375.075.555.757.12-
Long-Term Unearned Revenue
64.5769.6666.0456.6261.7247.5
Long-Term Deferred Tax Liabilities
23.0617.7917.7112.9756.8429.68
Other Long-Term Liabilities
----1.991.99
Total Liabilities
512.16550.03552.8833.59891.63571.41
Common Stock
466.13466.13466.13466.17466.21465.13
Additional Paid-In Capital
1,1281,1271,1401,1411,1351,115
Retained Earnings
2,7192,6392,3872,2041,8971,576
Treasury Stock
-17.69-17.69-34.77-0.57-1.12-1.86
Comprehensive Income & Other
17.2524.36-17.1425.33--
Total Common Equity
4,3134,2393,9413,8363,4973,153
Minority Interest
-0.150.42.052.032.070.44
Shareholders' Equity
4,3124,2393,9433,8383,4993,154
Total Liabilities & Equity
4,8254,7894,4964,6714,3913,725
Total Debt
6.346.686.9293.51279.4878.09
Net Cash (Debt)
1,8732,3771,9251,4841,6611,238
Net Cash Growth
40.64%23.45%29.70%-10.65%34.25%-41.73%
Net Cash Per Share
4.045.114.133.193.572.67
Filing Date Shares Outstanding
466.1453.53463.92464.69466.21465.13
Total Common Shares Outstanding
466.1453.53463.92466.17466.21465.13
Working Capital
2,6912,4702,0101,8081,9371,269
Book Value Per Share
9.259.358.498.237.506.78
Tangible Book Value
4,2484,1733,8763,7723,4343,096
Tangible Book Value Per Share
9.119.208.358.097.376.66
Buildings
-374.2291.93277.02270.37237.39
Machinery
-1,069974.9954.6942.59511.38
Construction In Progress
-33.5134.5143.0517388.72
Source: S&P Global Market Intelligence. Standard template. Financial Sources.